Bill

Bill > S4106


US S4106

US S4106
Rx ACCESS Act Rx Access, Choice, Cost Equity, and Supply Stability Act


summary

Introduced
03/17/2026
In Committee
03/17/2026
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A bill to amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes.

AI Summary

This bill, also known as the Rx Access, Choice, Cost Equity, and Supply Stability Act (Rx ACCESS Act), aims to improve access to medications for individuals covered by TRICARE, the healthcare program for U.S. military personnel and their families. Specifically, it allows eligible beneficiaries to choose how they receive non-generic maintenance medications starting October 1, 2026, and establishes new standards for how Pharmacy Benefit Managers (PBMs), companies that manage prescription drug benefits, are reimbursed by the Department of Defense. Under these new standards, retail pharmacies must be reimbursed at least their actual acquisition cost for a drug plus a professional dispensing fee equivalent to what the state pays under Medicaid (a government health insurance program for low-income individuals). The bill also prohibits PBMs from charging retail pharmacies hidden or retroactive fees and mandates annual audits by the Comptroller General of the United States to review reimbursement rates, pharmacy network adequacy, and beneficiary access, with reports submitted to Congress. The Secretary of Defense is required to submit a plan for implementing these changes within 90 days of the bill's enactment.

Committee Categories

Justice

Sponsors (3)

Last Action

Read twice and referred to the Committee on the Judiciary. (on 03/17/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...